In the animal model, BA decreases serum prostate-specific antigen (PSA) levels by 88%, inhibits the LNCap tumour growth by 38% and reduces insulin-like growth factor-1 in nude mice injected with human LNCap prostate cancer cells15. Here, KLK3 is linked to neoplasm.